Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition.

Sultan H, Kumai T, Fesenkova VI, Fan AE, Wu J, Cho HI, Kobayashi H, Harabuchi Y, Celis E.

Cancer Immunol Res. 2018 May;6(5):617-627. doi: 10.1158/2326-6066.CIR-17-0549. Epub 2018 Feb 26.

PMID:
29483127
2.

Designing therapeutic cancer vaccines by mimicking viral infections.

Sultan H, Fesenkova VI, Addis D, Fan AE, Kumai T, Wu J, Salazar AM, Celis E.

Cancer Immunol Immunother. 2017 Feb;66(2):203-213. doi: 10.1007/s00262-016-1834-5. Epub 2016 Apr 6. Review.

3.

Mechanism of action for the cytotoxic effects of the nitric oxide prodrug JS-K in murine erythroleukemia cells.

Kaczmarek MZ, Holland RJ, Lavanier SA, Troxler JA, Fesenkova VI, Hanson CA, Cmarik JL, Saavedra JE, Keefer LK, Ruscetti SK.

Leuk Res. 2014 Mar;38(3):377-82. doi: 10.1016/j.leukres.2013.12.002. Epub 2013 Dec 12.

4.

Expression of Co-stimulatory molecules on langerhans cells in lesional epidermis of human atopic dermatitis.

Fesenkova VI, Kurchenko AI, Castellani ML, Conti P, Anogeianaki A, Caraffa A, Kalogeromitros D.

Immunopharmacol Immunotoxicol. 2007;29(3-4):487-98.

PMID:
18075860
5.
6.

[Effect of erbisol on functional activity of T-helpers of type II in production of IL-4 and IL-10 in vitro].

Drannik HM, Fesenkova VI, Driians'ka VIe, Papakina VS, Nikolaienko OM, Nazar OV.

Lik Sprava. 2003 Apr-Jun;(3-4):113-7. Ukrainian.

PMID:
12889376

Supplemental Content

Loading ...
Support Center